TAZ also was found to promote the metastasis of aggressive patient-derived breast cancer cell lines [29] and, in pancreatic cancer, increased YAP could replace dependence on KRAS activity [30, 31]. The gene discussed is YAP1; the disease is pancreatic neoplasm.